Breaking News Instant updates and real-time market news.

XRX

Xerox

$29.95

0.34 (1.15%)

08:05
02/13/18
02/13
08:05
02/13/18
08:05

Xerox says Icahn, Deason letter 'misleading and inaccurate'

Xerox announced that its board has reviewed the February 12 letter signed by Carl Icahn and Darwin Deason, stating: "To date, the Board has chosen not to engage in a public debate with our two large shareholders. However, we believe their misleading and inaccurate Letter warrants a written response to ensure the facts are clear for all Xerox shareholders." In its response, Xerox added in part: "Mr. Icahn and Mr. Deason suggest through suspect math that investors are "selling control of Xerox for a cash flow multiple barely exceeding 2.3x." This analysis is just plain wrong. As discussed in prior presentations to investors, Xerox shareholders receive in the Transaction (i) a $2.5 billion dividend at closing; (ii) 49.9% of the combined Xerox and Fuji Xerox; and (iii) 49.9% of the benefit of the value created from at least $1.7 billion of annual cost savings, including $1.25 billion in cost synergies that are only achievable via this Transaction...Mr. Icahn's and Mr. Deason's suggestion of 'freeing the company from the shackles of the Fuji Xerox joint venture' is not a viable strategy...The agreement is a binding legal document that cannot be simply wished away, renegotiated or dissolved because Mr. Icahn and Mr. Deason desire it so...We believe the existence of the Fuji Xerox joint venture negatively impacts value in any other merger transaction. More likely, it would simply make such a transaction unattractive to any other strategic buyer. It is also not something that needs speculation: since the public speculation of a potential transaction with Fujifilm on January 10, 2018, no potential strategic buyer contacted Xerox, or its advisors, with any credible proposal or alternatives...As we made clear numerous times in our disclosures, of the $1.7 billion in total annual cost reductions by 2020, $1.25 billion is related to what we can achieve only by integrating the two companies, while the remaining $450 million comes from a Fuji Xerox-specific cost reduction program...Both Xerox and Fujifilm have a proven track record of executing significant transformations in the past, and are fully committed to realizing the full synergy upside from the combined company...Our full-year 2017 results clearly demonstrate that the strategy we have implemented is working as we met or exceeded every financial metric we guided to in 2017...In conclusion, Mr. Icahn and Mr. Deason fail to provide an actionable plan or any cogent ideas to make their scheme a reality. Following their playbook would be both highly irresponsible and unlikely to succeed, particularly given the terms and constraints of the existing Fuji Xerox joint venture agreement, and the realities of today's competitive environment."

  • 13

    Feb

XRX Xerox
$29.95

0.34 (1.15%)

12/07/17
LOOP
12/07/17
NO CHANGE
Target $38
LOOP
Buy
Xerox offers positive near-term outlook and cost savings, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $38 price target after meeting with management of Xerox yesterday. Baruah says the company continues to offer compelling near-term catalysts, namely a "reasonable December quarter guidance", 4-8 quarter setup with savings not accounted for by consensus, and incremental revenue growth initiatives. The analyst says the stock is valued attractively and should have traded up 5% rather than down 15% after the September quarter results, since it exceeded the Street operations metrics views excluding one-time items.
01/31/18
STPT
01/31/18
DOWNGRADE
STPT
Hold
Xerox downgraded to Hold from Buy at Standpoint Research
Standpoint Research analyst Ronnie Moas downgraded Xerox to Hold, citing the company's deal to merge with the Fuji Xerox joint venture.
02/05/18
UBSW
02/05/18
UPGRADE
Target $38
UBSW
Buy
Xerox upgraded to Buy from Neutral at UBS
UBS analyst Steven Milunovich upgraded Xerox to Buy and raised his price target for the shares to $38 from $34.50. The analyst is positive on "deal optionality" from the Fuji Xerox merger and notes the company's fundamentals are improved following the Q4 results. The market is underappreciating "upside optionality" from Fuji Xerox deal, according to which shareholders would receive $9.80 per share in cash and 50% of the new Fuji Xerox, Milunovich tells investors in a research note. His post-deal theoretical valuation for Xerox is $40 per share.
02/12/18
UBSW
02/12/18
NO CHANGE
Target $38
UBSW
Buy
UBS confident in potential deal between Xerox and Fujifilm
UBS analyst Steven Milunovich met with Xerox (XRX) management to discuss its potential deal with Fujifilm (FUJIY) and came away confident both were on the same page, that Jacobson is a good CEO choice to implement tough decisions, and that synergies will be achievable. Milunovich has a Buy rating and $38 price target on Xerox shares.

TODAY'S FREE FLY STORIES

ARNC

Arconic

$16.99

0.035 (0.21%)

11:10
06/22/18
06/22
11:10
06/22/18
11:10
Options
Arconic attracts a bullish option play as shares sit near 52-week lows »

Arconic attracts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUTL

Autolus Therapeutics

$0.00

(0.00%)

11:09
06/22/18
06/22
11:09
06/22/18
11:09
Syndicate
Breaking Syndicate news story on Autolus Therapeutics »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

CAR

Avis Budget

$42.45

1.2 (2.91%)

11:05
06/22/18
06/22
11:05
06/22/18
11:05
Options
Avis Budget call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUTL

Autolus Therapeutics

$0.00

(0.00%)

10:56
06/22/18
06/22
10:56
06/22/18
10:56
Syndicate
Breaking Syndicate news story on Autolus Therapeutics »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

10:55
06/22/18
06/22
10:55
06/22/18
10:55
General news
U.S. equities rolled over with yields after Trump tweeted »

U.S. equities rolled over…

10:55
06/22/18
06/22
10:55
06/22/18
10:55
Conference/Events
The FDA Blood Products Advisory Committee to hold a meeting »

The Committee hears…

IO

ION Geophysical

$20.65

-0.7 (-3.28%)

, SLB

Schlumberger

$67.40

2.61 (4.03%)

10:52
06/22/18
06/22
10:52
06/22/18
10:52
Periodicals
Supreme Court backs Schlumberger in patent fight with ION, Reuters reports »

The U.S. Supreme Court…

IO

ION Geophysical

$20.65

-0.7 (-3.28%)

SLB

Schlumberger

$67.40

2.61 (4.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

  • 20

    Jul

FNSR

Finisar

$17.03

-0.685 (-3.87%)

10:50
06/22/18
06/22
10:50
06/22/18
10:50
Options
Bearish option flow in Finisar as shares see relative weakness »

Bearish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

AUTL

Autolus Therapeutics

$0.00

(0.00%)

10:49
06/22/18
06/22
10:49
06/22/18
10:49
Syndicate
Autolus Therapeutics indicated to open at $30, IPO priced at $17.00 »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

10:47
06/22/18
06/22
10:47
06/22/18
10:47
Conference/Events
Wells Fargo analysts to hold an analyst/industry conference call »

Analysts provide a 3Q18…

NUVA

NuVasive

$55.81

0.33 (0.59%)

10:45
06/22/18
06/22
10:45
06/22/18
10:45
Conference/Events
NuVasive has a conference call hosted by JPMorgan »

JPMorgan Analyst Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

HAIN

Hain Celestial

$30.23

1.04 (3.56%)

10:40
06/22/18
06/22
10:40
06/22/18
10:40
Options
5K Hain Celestial Aug 29 - 31 call spreads sold at 85c »

5K Hain Celestial Aug 29…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APO

Apollo Global

$31.89

0.18 (0.57%)

, HCP

HCP

$24.78

0.15 (0.61%)

10:37
06/22/18
06/22
10:37
06/22/18
10:37
Periodicals
Apollo the buyer of HCP senior housing portfolio, Bloomberg reports »

HCP (HCP) on June 5 said…

APO

Apollo Global

$31.89

0.18 (0.57%)

HCP

HCP

$24.78

0.15 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$472.84

9.97 (2.15%)

10:35
06/22/18
06/22
10:35
06/22/18
10:35
Options
Expiring Chipotle calls en fuego as shares head toward $500 »

Expiring Chipotle calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 26

    Jul

PAGS

PagSeguro Digital

$30.52

1.1 (3.74%)

10:30
06/22/18
06/22
10:30
06/22/18
10:30
Options
Three-way spreads continue in PagSeguro »

Three-way spreads…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

GM

General Motors

$41.70

0.575 (1.40%)

, F

Ford

$11.82

0.115 (0.98%)

10:28
06/22/18
06/22
10:28
06/22/18
10:28
General news
Trump says 20% tariffs may be placed on all imported European cars »

President Trump just…

GM

General Motors

$41.70

0.575 (1.40%)

F

Ford

$11.82

0.115 (0.98%)

HMC

Honda

$30.76

0.1 (0.33%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$131.64

-1 (-0.75%)

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$19.48

0.315 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

10:25
06/22/18
06/22
10:25
06/22/18
10:25
Conference/Events
Stephens food/agribusiness analyst to hold an analyst/industry conference call »

Food & Agribusiness…

QGEN

Qiagen

$36.61

0.41 (1.13%)

10:25
06/22/18
06/22
10:25
06/22/18
10:25
Conference/Events
Qiagen participates in a conference call with William Blair »

CFO Sachers participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

CMC

Commercial Metals

$23.22

0.96 (4.31%)

10:22
06/22/18
06/22
10:22
06/22/18
10:22
Recommendations
Commercial Metals analyst commentary  »

Commercial Metals to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STG

Sunlands Online

$9.27

0.32 (3.58%)

, MU

Micron

$59.06

-0.38 (-0.64%)

10:21
06/22/18
06/22
10:21
06/22/18
10:21
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

STG

Sunlands Online

$9.27

0.32 (3.58%)

MU

Micron

$59.06

-0.38 (-0.64%)

IDXG

Interpace Diagnostics

$0.90

0.0262 (3.00%)

AYX

Alteryx

$37.60

-1.03 (-2.67%)

BCRX

BioCryst

$5.55

-0.225 (-3.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 10

    Jul

  • 12

    Jul

NKE

Nike

$74.13

0.19 (0.26%)

, CAKE

Cheesecake Factory

$58.01

-1.86 (-3.11%)

10:21
06/22/18
06/22
10:21
06/22/18
10:21
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

NKE

Nike

$74.13

0.19 (0.26%)

CAKE

Cheesecake Factory

$58.01

-1.86 (-3.11%)

HZN

Horizon Global

$6.52

-0.74 (-10.19%)

BKNG

Booking Holdings

$2,108.13

-13.8 (-0.65%)

VRX

Valeant

$24.26

-0.46 (-1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 27

    Aug

URI

United Rentals

$158.72

5.56 (3.63%)

, DG

Dollar General

$99.78

1.09 (1.10%)

10:21
06/22/18
06/22
10:21
06/22/18
10:21
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

URI

United Rentals

$158.72

5.56 (3.63%)

DG

Dollar General

$99.78

1.09 (1.10%)

SO

Southern Company

$45.34

0.04 (0.09%)

ES

Eversource

$56.09

0.39 (0.70%)

DRI

Darden

$107.60

0.53 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

  • 17

    Jul

IO

ION Geophysical

$21.85

0.5 (2.34%)

, SLB

Schlumberger

$67.20

2.41 (3.72%)

10:21
06/22/18
06/22
10:21
06/22/18
10:21
Periodicals
Schlumberger wins high court patent ruling over ION Geophysical, Bloomberg says »

Ion Geophysical (IO)…

IO

ION Geophysical

$21.85

0.5 (2.34%)

SLB

Schlumberger

$67.20

2.41 (3.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 28

    Jun

  • 20

    Jul

WMT

Walmart

$84.47

0.25 (0.30%)

10:20
06/22/18
06/22
10:20
06/22/18
10:20
Periodicals
Walmart-Advent deal gets Brazil antitrust approval, Reuters reports »

Brazil's antitrust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PX

Praxair

$157.72

2 (1.28%)

10:20
06/22/18
06/22
10:20
06/22/18
10:20
Options
Praxair calls active as shares see strength »

Praxair calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.